The Lescol ® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease (Q58088776)
journal article; published in Acute Cardiac Care in 2001
Language:
(P31) (Q13442814)
(P50) (Q62706082)
(P304) 165-172
(P407) (Q1860)
(P433) 4
(P478) 4
(P577) Saturday, December 1, 2001
(P856) https://www.tandfonline.com/doi/abs/10.1080/14628840127765
(P921) (Q269829)
(Q190805)
(Q844935)
(P1433) (Q27719162)
(P1476) "The Lescol(R) Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease" (language: en)
(P2093) Patrick WJC Serruys
Renée Benghozi
Paul G Hugenholtz
Pim J De Feyter
Emmanuel Lesaffre
(P2860) (Q28257680)
(Q38507399)
(Q40913054)
(Q34687253)
(Q29547825)
(Q29547887)
(Q33940282)
(Q51032413)
(Q56780258)
(Q28248823)
(Q29620696)
(Q68679742)
(Q73986492)
(Q68564239)
(Q67514041)
(Q73606171)
(Q73038843)
(Q72285036)
(Q72714228)
(Q74601678)
(Q74319612)
(Q77530104)
(Q72220309)
(Q69664288)
(Q78171852)
other details
description journal article; published in Acute Cardiac Care in 2001

External Links